skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and /sup 45/Ca-fluxes in the rabbit aorta

Journal Article · · Am. J. Hypertens.; (United States)
DOI:https://doi.org/10.1093/ajh/1.3.262· OSTI ID:6925260

Vinpocetine is a highly specific inhibitor of calmodulin-dependent phosphodiesterase (CaM-PDE) with an IC50 of 19 microM and produces a significant accumulation of cyclic GMP but not cyclic AMP in rabbit aorta. In isolated rabbit aortic strips, vinpocetine (0.01 and 0.1 mM) inhibited the contraction and /sup 45/Ca uptake due to both phenylephrine (1 microM) and KCl (40 mM), whereas 8-Br-cyclic GMP (0.1-1mM) selectively impaired phenylephrine-induced responses. Furthermore, the KCl-stimulated /sup 45/Ca efflux in normal Ca2+ buffer, which reflects elevated cytosolic Ca2+, was greatly diminished by vinpocetine but not by 8-Br-cyclic GMP. However, phenylephrine-induced /sup 45/Ca efflux and contraction in Ca2+-free buffer, which reflect Ca2+ release from intracellular sites, were similarly inhibited by both vinpocetine and 8-Br-cyclic GMP. The results suggest that vinpocetine may effect vasodilatation through blockade of the slow channel and selective inhibition of CaM-PDE in the vascular smooth muscle.

Research Organization:
Schering-Plough Corporation, Bloomfield, NJ (USA)
OSTI ID:
6925260
Journal Information:
Am. J. Hypertens.; (United States), Vol. 1
Country of Publication:
United States
Language:
English